These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 9153871)

  • 1. [Maggot therapy for gangrene and osteomyelitis].
    Mumcuoglu KY; Lipo M; Ioffe-Uspensky I; Miller J; Galun R
    Harefuah; 1997 Mar; 132(5):323-5, 382. PubMed ID: 9153871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Maggot therapy in wound management].
    Falch BM; de Weerd L; Sundsfjord A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1864-7. PubMed ID: 19844278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Maggots of Lucilia sericata in treatment of intractable wounds].
    Orkiszewski M
    Wiad Lek; 2007; 60(7-8):381-5. PubMed ID: 18175560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications for maggots in wound care.
    Mumcuoglu KY
    Am J Clin Dermatol; 2001; 2(4):219-27. PubMed ID: 11705249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
    Gilead L; Mumcuoglu KY; Ingber A
    J Wound Care; 2012 Feb; 21(2):78, 80, 82-85. PubMed ID: 22584527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presurgical maggot debridement of soft tissue wounds is associated with decreased rates of postoperative infection.
    Sherman RA; Shimoda KJ
    Clin Infect Dis; 2004 Oct; 39(7):1067-70. PubMed ID: 15472863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.
    Paul AG; Ahmad NW; Lee HL; Ariff AM; Saranum M; Naicker AS; Osman Z
    Int Wound J; 2009 Feb; 6(1):39-46. PubMed ID: 19291114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy.
    Sherman RA
    Diabetes Care; 2003 Feb; 26(2):446-51. PubMed ID: 12547878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary evaluation of maggot (Diptera: Calliphoridae) therapy as a potential treatment for leishmaniasis ulcers].
    Arrivillaga J; Rodríguez J; Oviedo M
    Biomedica; 2008 Jun; 28(2):305-10. PubMed ID: 18719732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae.
    Nuesch R; Rahm G; Rudin W; Steffen I; Frei R; Rufli T; Zimmerli W
    Infection; 2002 Oct; 30(5):306-9. PubMed ID: 12382092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maggot debridement therapy and complementary wound care: a case series from Nigeria.
    Yusuf MA; Ibrahim BM; Oyebanji AA; Abubakar F; Ibrahim M; Ibrahim Jalo R; Aminu A; Akbarzadeh K; Azam M; Sheshe AA; Ganiyu OO; Abubakar MK; Salisu WJ; Kordshouli RS; Adamu AY; Takalmawa H; Daneji I; Aliyu M; Ibrahim MG; Kabuga AI; Abdullahi AS; Abbas MA
    J Wound Care; 2022 Nov; 31(11):996-1005. PubMed ID: 36367805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AN OVERVIEW OF OSTEOMYELITIS WITH REFERENCE TO TREATMENT IN PARTICULAR MAGGOT DEBRIDEMENT THERAPY (MDT).
    El-Tawdy AHF; Ibrahim EAH; Morsy TA
    J Egypt Soc Parasitol; 2016 Dec; 46(3):613-624. PubMed ID: 30230758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of suppurative chronic wounds with maggot debridement therapy].
    Mumcuoğlu KY; Taylan Ozkan A
    Turkiye Parazitol Derg; 2009; 33(4):307-15. PubMed ID: 20101584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal debridement in the treatment of Fournier's gangrene.
    Frezza EE; Atlas I
    Am Surg; 1999 Nov; 65(11):1031-4. PubMed ID: 10551751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the use of maggots in wound therapy.
    Gupta A
    Ann Plast Surg; 2008 Feb; 60(2):224-7. PubMed ID: 18216520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
    Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
    J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing attitudes toward maggot debridement therapy in wound treatment: a review and discussion.
    King C
    J Wound Care; 2020 Feb; 29(Sup2c):S28-S34. PubMed ID: 32058840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.
    Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ
    BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of Maggot therapy for Fournier's gangrene.
    Fonseca-Muñoz A; Sarmiento-Jiménez HE; Pérez-Pacheco R; Thyssen PJ; Sherman RA
    Int Wound J; 2020 Dec; 17(6):1642-1649. PubMed ID: 32691532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management of osteomyelitis in the feet of diabetic patients.
    Venkatesan P; Lawn S; Macfarlane RM; Fletcher EM; Finch RG; Jeffcoate WJ
    Diabet Med; 1997 Jun; 14(6):487-90. PubMed ID: 9212316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.